Updated:
CODA Biotherapeutics
CODA Biotherapeutics is a preclinical-stage biopharmaceutical company developing a chemogenetic gene therapy platform. The platform controls neuronal activity...
CODA Biotherapeutics
CODA Biotherapeutics is a preclinical-stage biopharmaceutical company developing a chemogenetic gene therapy platform. The platform controls neuronal activity to treat intractable diseases by modifying target populations with gene therapy. This involves expressing a tunable ligand-gated ion channel in neurons that responds to a proprietary small molecule.
General information
Firm type
Asset Manager
Location
Region
North America
Country
United States
City
South San Francisco
Corporate office
South San Francisco, CA, United States
Sector focus
Frequently asked questions
What is CODA Biotherapeutics?
CODA Biotherapeutics is a asset manager headquartered in South San Francisco, United States.
Where is CODA Biotherapeutics headquartered?
CODA Biotherapeutics is headquartered in South San Francisco, United States, in the North America region.
What does Altss track for CODA Biotherapeutics?
Altss maintains an OSINT-verified profile of CODA Biotherapeutics covering investment focus (ESG policy, ticket size, target IRR, currency preference, regional focuses, industry focuses, technological focuses), team (service providers and advisors), deals (company deals and fund commitments), and network (associations and event participation). Detailed values are available to Altss subscribers.
What is CODA Biotherapeutics's website?
CODA Biotherapeutics's public website is www.codabiotherapeutics.com. Verified contact details for principals and decision-makers are available to Altss subscribers.
What type of firm is CODA Biotherapeutics?
CODA Biotherapeutics is classified by Altss as a Asset Manager, operating from United States within the North America region.
How does Altss source intelligence on CODA Biotherapeutics?
Altss combines OSINT (open-source intelligence) with regulatory filings, public disclosures, and licensed data partners. Source provenance is tracked to support compliance-ready research workflows.
When was CODA Biotherapeutics's Altss profile last updated?
CODA Biotherapeutics's profile on Altss was last refreshed on June 3, 2026. Continuous updates are applied as new public information is verified.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: